Cite
Therapeutic hyperthermia regulates complement C3 activation and suppresses tumor development through HSPA5/NFκB/CD55 pathway in nasopharyngeal carcinoma.
MLA
Chen, Chengcong, et al. “Therapeutic Hyperthermia Regulates Complement C3 Activation and Suppresses Tumor Development through HSPA5/NFκB/CD55 Pathway in Nasopharyngeal Carcinoma.” Clinical & Experimental Immunology, vol. 213, no. 2, Aug. 2023, pp. 221–34. EBSCOhost, https://doi.org/10.1093/cei/uxad060.
APA
Chen, C., Ren, A., Yi, Q., Cai, J., Khan, M., Lin, Y., Huang, Z., Lin, J., Zhang, J., Liu, W., Xu, A., Tian, Y., Yuan, Y., & Zheng, R. (2023). Therapeutic hyperthermia regulates complement C3 activation and suppresses tumor development through HSPA5/NFκB/CD55 pathway in nasopharyngeal carcinoma. Clinical & Experimental Immunology, 213(2), 221–234. https://doi.org/10.1093/cei/uxad060
Chicago
Chen, Chengcong, Anbang Ren, Qi Yi, Jiazuo Cai, Muhammad Khan, Yunen Lin, Zhong Huang, et al. 2023. “Therapeutic Hyperthermia Regulates Complement C3 Activation and Suppresses Tumor Development through HSPA5/NFκB/CD55 Pathway in Nasopharyngeal Carcinoma.” Clinical & Experimental Immunology 213 (2): 221–34. doi:10.1093/cei/uxad060.